MAM
Avian Media launches new financial vertical
MUMBAI: Avian Media, a specialist communications consultancy, has launched a specialised financial communications practice.
Dedicated to supporting the investor relations and public relations needs of financial services companies, the company has appointed Mehul Mehta as the group business director to head the vertical.
 |
|---|
On the new vertical, Avian Media, CEO and business partner Nitin Mantri said, ‘The setting up of a dedicated financial communications practice is a logical and strategic next step for us. The new initiative leverages Avian Media‘s expertise and experience, including deep and varied industry knowledge, to offer clients innovative and result-oriented strategic communications campaigns. We are delighted to welcome Mehul on board to spearhead this exciting new vertical. His extensive experience in the IR and BFSI sector coupled with our experience in corporate PR, ideally positions this practice for growth and success.”
A chartered accountant by qualification, Mehul has over 16 years of professional experience. He started his career as an equity research analyst with KenSource Information Services, after which he set up a company to deal with perception mapping for the Investor Community. Before joining Avian Media, Mehul was the Director at a research agency focusing on ‘Investor behaviour’.
Commenting on his appointment, Mehta, said, “I look forward to developing and growing Avian Media’s financial services offering.The BFSI company’s need fresh thinking and strategic counselling while communicating with different set of stakeholders. Building on from Avian Media’s extensive expertise across various sectors, through this new offering, we hope to bring clients, deep insights and result-oriented financial communications campaigns.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
